However, only a small proportion of HCC patients actually respond to ICIs, and one of the important reasons for this may be HCC expression of PD-1 and the infiltration of CD4+ and CD8+ T cells (Sia et al., 2017; Kurebayashi et al., 2018; Kudo, 2020a). Here, PDCD1 is linked to hepatocellular carcinoma.